Caviness JN - Search Results

1

Conjugal Synucleinopathies: A Clinicopathologic Study.

Adler CH, Halverson M, Zhang N, Shill HA, Driver-Dunckley E, Mehta SH, Atri A, Caviness JN, Serrano GE, Shprecher DR, Belden CM, Sabbagh MN, Long K, Beach TG. Adler CH, et al. Among authors: caviness jn. Mov Disord. 2024 Apr 10. doi: 10.1002/mds.29783. Online ahead of print. Mov Disord. 2024. PMID: 38597193

2

Defining mild cognitive impairment in Parkinson's disease.

Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, Evidente VG, Shill HA, Adler CH. Caviness JN, et al. Mov Disord. 2007 Jul 15;22(9):1272-7. doi: 10.1002/mds.21453. Mov Disord. 2007. PMID: 17415797

3

Incidental Lewy body disease: clinical comparison to a control cohort.

Adler CH, Connor DJ, Hentz JG, Sabbagh MN, Caviness JN, Shill HA, Noble B, Beach TG. Adler CH, et al. Among authors: caviness jn. Mov Disord. 2010 Apr 15;25(5):642-6. doi: 10.1002/mds.22971. Mov Disord. 2010. PMID: 20175211 Free PMC article.

4

Parkinson's disease, cortical dysfunction, and alpha-synuclein.

Caviness JN, Lue LF, Beach TG, Hentz JG, Adler CH, Sue L, Sadeghi R, Driver-Dunckley E, Evidente VG, Sabbagh MN, Shill HA, Walker DG. Caviness JN, et al. Mov Disord. 2011 Jul;26(8):1436-42. doi: 10.1002/mds.23697. Epub 2011 May 3. Mov Disord. 2011. PMID: 21542019 Free PMC article.

5

Cortical phosphorylated α-Synuclein levels correlate with brain wave spectra in Parkinson's disease.

Caviness JN, Lue LF, Hentz JG, Schmitz CT, Adler CH, Shill HA, Sabbagh MN, Beach TG, Walker DG. Caviness JN, et al. Mov Disord. 2016 Jul;31(7):1012-9. doi: 10.1002/mds.26621. Epub 2016 Apr 8. Mov Disord. 2016. PMID: 27062301 Free PMC article.

6

Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation.

Pal GD, Ouyang B, Serrano G, Shill HA, Goetz C, Stebbins G, Metman LV, Driver-Dunckley E, Mehta SH, Caviness JN, Sabbagh MN, Adler CH, Beach TG; Arizona Study of Aging Neurodegenerative Disorders. Pal GD, et al. Among authors: caviness jn. Mov Disord. 2017 Feb;32(2):274-277. doi: 10.1002/mds.26882. Epub 2016 Dec 2. Mov Disord. 2017. PMID: 27911008

7

Neuropathological Findings in Parkinson's Disease With Mild Cognitive Impairment.

Knox MG, Adler CH, Shill HA, Driver-Dunckley E, Mehta SA, Belden C, Zamrini E, Serrano G, Sabbagh MN, Caviness JN, Sue LI, Davis KJ, Dugger BN, Beach TG. Knox MG, et al. Among authors: caviness jn. Mov Disord. 2020 May;35(5):845-850. doi: 10.1002/mds.27991. Epub 2020 Feb 8. Mov Disord. 2020. PMID: 32034933

8

Effective treatment of orthostatic tremor with gabapentin.

Evidente VG, Adler CH, Caviness JN, Gwinn KA. Evidente VG, et al. Among authors: caviness jn. Mov Disord. 1998 Sep;13(5):829-31. doi: 10.1002/mds.870130513. Mov Disord. 1998. PMID: 9756154

9

Electrophysiological observations in hereditary parkinsonism-dementia with Lewy body pathology.

Caviness JN, Gwinn-Hardy K, Adler CH, Muenter MD. Caviness JN, et al. Mov Disord. 2000 Jan;15(1):140-5. doi: 10.1002/1531-8257(200001)15:1<140::aid-mds1022>3.0.co;2-5. Mov Disord. 2000. PMID: 10634254

10

Serum leptin concentrations and satiety in Parkinson's disease patients with and without weight loss.

Evidente VG, Caviness JN, Adler CH, Gwinn-Hardy KA, Pratley RE. Evidente VG, et al. Among authors: caviness jn. Mov Disord. 2001 Sep;16(5):924-7. doi: 10.1002/mds.1165. Mov Disord. 2001. PMID: 11746624

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page